Sofinnova Raises €333m For European Biotech Fund

Venture Capital Firm’s Funds Worth €2bn

 
• By Andrew McConaghie

Global investors back Paris-headquartered Sofinnova to recoup investment in life science start-ups.

Paris
Paris-based Sofinnova attracted investors from Europe and beyond

More from Business

More from Scrip